Literature DB >> 25998393

MafB antagonizes phenotypic alteration induced by GM-CSF in microglia.

Ryusuke Koshida1, Hisashi Oishi2, Michito Hamada3, Satoru Takahashi3.   

Abstract

Microglia are tissue-resident macrophages which are distributed throughout the central nervous system (CNS). Recent studies suggest that microglia are a unique myeloid population distinct from peripheral macrophages in terms of origin and gene expression signature. Granulocyte-macrophage colony-stimulating factor (GM-CSF), a pleiotropic cytokine regulating myeloid development, has been shown to stimulate proliferation and alter phenotype of microglia in vitro. However, how its signaling is modulated in microglia is poorly characterized. MafB, a bZip transcriptional factor, is highly expressed in monocyte-macrophage lineage cells including microglia, although its role in microglia is largely unknown. We investigated the crosstalk between GM-CSF signaling and MafB by analyzing primary microglia. We found that Mafb-deficient microglia grew more rapidly than wild-type microglia in response to GM-CSF. Moreover, the expression of genes associated with microglial differentiation was more downregulated in Mafb-deficient microglia cultured with GM-CSF. Notably, such differences between the genotypes were not observed in the presence of M-CSF. In addition, we found that Mafb-deficient microglia cultured with GM-CSF barely extended their membrane protrusions, probably due to abnormal activation of RhoA, a key regulator of cytoskeletal remodeling. Altogether, our study reveals that MafB is a negative regulator of GM-CSF signaling in microglia. These findings could provide new insight into the modulation of cytokine signaling by transcription factors in microglia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GM-CSF; MafB; Membrane protrusion; Microglia; RhoA

Mesh:

Substances:

Year:  2015        PMID: 25998393     DOI: 10.1016/j.bbrc.2015.05.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  Transcriptional and Epigenetic Regulation of Microglia in Health and Disease.

Authors:  Hana Yeh; Tsuneya Ikezu
Journal:  Trends Mol Med       Date:  2018-12-18       Impact factor: 11.951

Review 2.  Transcriptional control of microglia phenotypes in health and disease.

Authors:  Inge R Holtman; Dylan Skola; Christopher K Glass
Journal:  J Clin Invest       Date:  2017-07-31       Impact factor: 14.808

3.  Transcriptional regulation of homeostatic and disease-associated-microglial genes by IRF1, LXRβ, and CEBPα.

Authors:  Tianwen Gao; Janna Jernigan; Syed Ali Raza; Eric B Dammer; Hailian Xiao; Nicholas T Seyfried; Allan I Levey; Srikant Rangaraju
Journal:  Glia       Date:  2019-07-13       Impact factor: 7.452

4.  HDAC Inhibitor Sodium Butyrate-Mediated Epigenetic Regulation Enhances Neuroprotective Function of Microglia During Ischemic Stroke.

Authors:  Radhika Patnala; Thiruma V Arumugam; Neelima Gupta; S Thameem Dheen
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

Review 5.  Microglial signatures and their role in health and disease.

Authors:  Oleg Butovsky; Howard L Weiner
Journal:  Nat Rev Neurosci       Date:  2018-10       Impact factor: 34.870

6.  The Cell Culture Environment Regulates the Transcription Factor MafB in BV-2 Microglia.

Authors:  Patrick Miller-Rhodes; Harris A Gelbard
Journal:  Matters (Zur)       Date:  2021-01-29

7.  Differences in Immune-Related Genes Underlie Temporal and Regional Pathological Progression in 3xTg-AD Mice.

Authors:  Adelaide Fernandes; Cláudia Caldeira; Carolina Cunha; Elisabete Ferreiro; Ana Rita Vaz; Dora Brites
Journal:  Cells       Date:  2022-01-01       Impact factor: 6.600

8.  In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia.

Authors:  Tanja Wostradowski; Chittappen Kandiyil Prajeeth; Viktoria Gudi; Jessica Kronenberg; Sina Witte; Marina Brieskorn; Martin Stangel
Journal:  J Neuroinflammation       Date:  2016-09-22       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.